Form 4: ASP Isotopes Interim CEO Sells 25,000 Shares
Insider Transaction Report
Robert Ainscow, Interim CEO and COO of ASP Isotopes Inc., sold 25,000 shares of common stock on November 25, 2025, at a weighted average price of $5.769 per share.
Summary
- Robert Ainscow, Interim CEO and COO of ASP Isotopes Inc. (ASPI), sold 25,000 shares of common stock.
- The transaction occurred on November 25, 2025.
- The shares were sold at a weighted average price of $5.769 per share.
- Individual sales prices ranged from $5.54 to $6.015 per share.
- The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2024.
- Following the transaction, Mr. Ainscow directly beneficially owns 1,554,693 shares of common stock.
Sentiment
Score: 4
Explanation: The sale of shares by an Interim CEO, even if pre-planned under a 10b5-1 plan, can be perceived as a slightly negative signal by the market, indicating a potential lack of stronger conviction or a move to diversify personal holdings. However, the pre-planned nature mitigates some of the immediate negative implications.
Negatives
- An insider, the Interim CEO and COO, sold a significant number of shares (25,000).
- While part of a pre-arranged 10b5-1 plan, insider selling can sometimes be interpreted by the market as a lack of stronger confidence or a move to diversify holdings.
Risks
- Potential negative market perception due to insider selling, which could impact the company's share price.
Future Outlook
N/A
Industry Context
N/A. This filing reports an individual insider transaction and does not provide broader industry context.
Stakeholder Impact
- Shareholders: May interpret the insider sale as a signal regarding the company's future prospects or the insider's confidence, potentially influencing stock price.
Key Dates
| Date | Description |
|---|---|
| 12/13/2024 | Date Robert Ainscow adopted the Rule 10b5-1 trading plan. |
| 11/25/2025 | Date of the reported transaction where 25,000 shares were sold. |
| 11/28/2025 | Date the Form 4 was signed by Donald Ainscow as attorney-in-fact. |
Keywords
ASP Isotopes, ASPI, Robert Ainscow, Insider Sale, Form 4, CEO, COO, Stock Transaction, 10b5-1 Plan, Equity Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.